Biologics and Biosimilars: PhRMA launched a new section of its website this week to provide educational resources on biologics and biosimilars. Check it out now.
Ask About Adherence: Recent research on diabetes found many patients fail to meet treatment guidelines. Read the latest “Ask About Adherence” post to learn more about the importance of diabetes treatment intensification.
Local Impact: On average, Medicaid programs spent just 4.5 percent on prescription drugs in 2015. Take a look at PhRMA’s new map, which shows state-by-state Medicaid spending on medicine.
The Value of Innovation: Medicine development is vital in lowering health care spending by reducing the amount of labor needed for care. Read on about how medicines reduce costs.
Combating Drug Abuse: Every day, almost 7,000 people are treated in emergency rooms for inappropriate use of prescription drugs use. Learn more about PhRMA’s policies to combat drug abuse.
I’m Not Average: Innovative medicines have helped patients live longer, healthier lives. Join the online “I’m Not Average” community to share your story as a patient, caregiver or loved one and show your support for those that are fighting.
Medicare Monday: Through Part D coverage, seniors have access to medicines that help treat cardiovascular diseases, and there are 190 medicines in development to treat heart disease and stroke. Read more about how adherence helps improve seniors’ health.
Priscilla VanderVeer Priscilla VanderVeer Priscilla VanderVeer is a vice president, public affairs, at PhRMA. Ms. VanderVeer has more than 15 years of experience communicating important health care issues to a wide variety of audiences, including medical, health and patient advocates; policymakers and opinion-leaders; and the general public. At PhRMA, Ms. VanderVeer leads the development and execution of communications strategies and activities for the organization’s key state advocacy priorities. She lives in Annapolis, Maryland with her husband, Ken and their two dogs: Bea Arthur, a tiny 5 lb. Maltese and Henry, a slightly larger-than-average Yorkshire Terrier.